02.14.14
The global refurbished medical equipment/device market is poised to grow by 7.8 percent over the next four years to reach $8.45 billion by 2017, according to a recent report.
The market --- worth about $5.8 billion in 2012 --- encompasses devices for imaging-diagnostic-monitoring systems (X-ray, C-arm, ultrasound, computed tomography, fixed and mobile MRI [magnetic resonance imaging], cath labs, PET and SPECT system, radiation oncology systems [linear accelerator systems, HDR systems], minimally invasive devices [catheters, endoscopes, guidewires, atherectomy devices, balloon pumps, embolization devices and vascular closure device], biotechnology instruments [molecular diagnostic devices - chromatography systems, electrophoresis systems, spectroscopic devices, immunoassay analyzers, sequencers and synthesizers, and PCR thermal cyclers] and lab instruments [centrifuge, homogenizers, incubators, and flow cytometers] and others.
The refurbished medical devices market is driven by affordable product offerings and is experiencing stringent regulation on importation of these devices in the world market, the MarketsandMarkets report states.
Demand for these devices varies worldwide, with North America and Latin America generously accepting them and Europe mostly rejecting them (socialized medicine looks down upon such products). Asia and the Middle East are promising markets, though countries like China, Australia and Japan restrict refurbished medical device imports.
The worldwide market for refurbished medical devices principally is commanded by major multinationals such as GE Healthcare, Siemens Healthcare, Philips Healthcare, Stryker Corporation, Johnson & Johnson and Toshiba Medical Systems as well as third party vendors including Soma Technology, Agito Medical, DMS Topline Medical, and First Source Inc.
MarketsandMarkets is a global market research and consulting company that publishes strategically analyzed research reports on 13 industries, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT (information technology).
The market --- worth about $5.8 billion in 2012 --- encompasses devices for imaging-diagnostic-monitoring systems (X-ray, C-arm, ultrasound, computed tomography, fixed and mobile MRI [magnetic resonance imaging], cath labs, PET and SPECT system, radiation oncology systems [linear accelerator systems, HDR systems], minimally invasive devices [catheters, endoscopes, guidewires, atherectomy devices, balloon pumps, embolization devices and vascular closure device], biotechnology instruments [molecular diagnostic devices - chromatography systems, electrophoresis systems, spectroscopic devices, immunoassay analyzers, sequencers and synthesizers, and PCR thermal cyclers] and lab instruments [centrifuge, homogenizers, incubators, and flow cytometers] and others.
The refurbished medical devices market is driven by affordable product offerings and is experiencing stringent regulation on importation of these devices in the world market, the MarketsandMarkets report states.
Demand for these devices varies worldwide, with North America and Latin America generously accepting them and Europe mostly rejecting them (socialized medicine looks down upon such products). Asia and the Middle East are promising markets, though countries like China, Australia and Japan restrict refurbished medical device imports.
The worldwide market for refurbished medical devices principally is commanded by major multinationals such as GE Healthcare, Siemens Healthcare, Philips Healthcare, Stryker Corporation, Johnson & Johnson and Toshiba Medical Systems as well as third party vendors including Soma Technology, Agito Medical, DMS Topline Medical, and First Source Inc.
MarketsandMarkets is a global market research and consulting company that publishes strategically analyzed research reports on 13 industries, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT (information technology).